These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17205092)

  • 21. Health-related quality of life--an economist's perspective.
    de Pouvourville G; Borget I; Schlumberger M
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):786-7. PubMed ID: 17909541
    [No Abstract]   [Full Text] [Related]  

  • 22. Affordability--the forgotten criterion in health-care priority setting.
    Cleary SM; McIntyre D
    Health Econ; 2009 Apr; 18(4):373-5. PubMed ID: 19267322
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of guaranteed care for orthopedic patients].
    Dalén T; Herberts P; Johnell O; Persson M; Thorngren KG
    Lakartidningen; 1991 Dec; 88(50):4317-9. PubMed ID: 1774961
    [No Abstract]   [Full Text] [Related]  

  • 24. [Euthanasia in anesthesiology and intensive care. Intensive care, resource management and a dignified death].
    Steen PA
    Tidsskr Nor Laegeforen; 1990 Jun; 110(16):2082-3. PubMed ID: 2368073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fair distribution and prioritization of health care].
    Norup MS; Rossel P
    Ugeskr Laeger; 2004 Jun; 166(24):2348-51. PubMed ID: 15281575
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Should medical errors be avoided at any price?].
    Kristiansen IS
    Tidsskr Nor Laegeforen; 2000 Oct; 120(26):3178-83. PubMed ID: 11109368
    [No Abstract]   [Full Text] [Related]  

  • 28. [Not Available].
    Hermerén G; Sahlin NE
    Lakartidningen; 2018 Jun; 115():. PubMed ID: 29893982
    [No Abstract]   [Full Text] [Related]  

  • 29. CEA is not a price control.
    Cohen J
    Health Aff (Millwood); 2007; 26(5):1505; author reply 1506-7. PubMed ID: 17848464
    [No Abstract]   [Full Text] [Related]  

  • 30. Doing more with less: the challenge facing state oral health efforts.
    Gehshan S
    J Public Health Dent; 2012; 72 Suppl 1():S46-7. PubMed ID: 22433100
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions.
    Richardson G; Kennedy A; Reeves D; Bower P; Lee V; Middleton E; Gardner C; Gately C; Rogers A
    J Epidemiol Community Health; 2008 Apr; 62(4):361-7. PubMed ID: 18339831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Time for an efficiency assessment system for patients with schizophrenia].
    Nordén T; Arnlind M; Blecher R; Malm U; Nilsson C; Olausson G; Wanén M
    Lakartidningen; 1991 Jul; 88(30-31):2511-3. PubMed ID: 1907702
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.
    Turner DA; Paul S; Stone MA; Juarez-Garcia A; Squire I; Khunti K
    Heart; 2008 Dec; 94(12):1601-6. PubMed ID: 18450843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A note on the nature of utility in time and health and implications for cost utility analysis.
    Buckingham KJ; Devlin NJ
    Soc Sci Med; 2009 Jan; 68(2):362-7. PubMed ID: 19019518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life after stroke: review of the literature and implications for future research.
    Tseng MC; Lin HJ
    Acta Neurol Taiwan; 2007 Mar; 16(1):7-12. PubMed ID: 17486727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer; 2008 Mar; 112(5):1058-65. PubMed ID: 18186497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health priorities for developing countries: importance of non-fatal but disabling conditions.
    Olusanya BO
    Trans R Soc Trop Med Hyg; 2006 Nov; 100(11):1089-90. PubMed ID: 16935315
    [No Abstract]   [Full Text] [Related]  

  • 38. [The cost per year of life gained: trends and internal contradictions].
    van Dam J
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):441; author reply 441-2. PubMed ID: 17343145
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness of aortic valve replacement in the elderly: an introductory study.
    Wu Y; Jin R; Gao G; Grunkemeier GL; Starr A
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):608-13. PubMed ID: 17320552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-HPV vaccination: a review of recent economic data for Italy.
    Mennini FS; Costa S; Favato G; Picardo M
    Vaccine; 2009 May; 27 Suppl 1():A54-61. PubMed ID: 19480963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.